Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
arm, capitalizable, constraint, contact, core, counterparty, culmination, distinct, earn, earned, goodwill, infection, intraperiod, IP, licensee, melanoma, NaN, predominant, predominantly, prostate, randomized, reopened, salt, SC, Simplifying, simultaneously, standalone, thousand, twelve, upcoming, Watertown, workplace
Removed:
accustomed, activation, ADCC, cellular, CEO, compensatory, cumulatively, cytotoxicity, detailed, dialog, discouraging, exempt, experiencing, fifteen, gamma, hereof, impacting, issuable, issuer, leading, leverage, minimize, moving, participating, Pfizer, precautionary, prefer, restricting, selected, worsen
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view